Business Context and Reporting Period
Company: Chicago Atlantic BDC, Inc. (Ticker: LIEN)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: An externally managed, closed-end, non-diversified Business Development Company (BDC) and Regulated Investment Company (RIC). The Company focuses on investing in highly complex and regulated industries, primarily the cannabis ecosystem, via direct loans to privately held companies. It also invests in growth/technology, esoteric/asset-based lending, and liquidity solutions.
Key Event: On October 1, 2024, the Company completed a Loan Portfolio Acquisition from Chicago Atlantic Loan Portfolio, LLC (CALP), issuing 16.6 million shares in exchange for a loan portfolio valued at approximately $219.6 million. This transaction significantly expanded the portfolio size.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Total Investment Portfolio (Fair Value) | $333.3 million | $275.2 million |
| Total Investment Income | $54.3 million | $21.7 million |
| Net Investment Income | $33.1 million | $9.5 million |
| Net Increase in Net Assets from Operations | $33.3 million | $9.6 million |
| Net Asset Value (NAV) per Share | $13.30 | $13.20 |
| Market Price per Share (Dec 31, 2025) | $10.33 | $12.19 |
| Discount to NAV | ~22.3% | ~7.4% |
| Total Debt Outstanding | $25.0 million | $0 |
| Cash and Cash Equivalents | $2.9 million | $23.9 million |
| Dividends Declared per Share (Annual) | $1.36 | $1.09 |
Material Changes vs. Prior Period
- Portfolio Growth: The investment portfolio grew by approximately 21% (from $275.2M to $333.3M) driven by the 2024 Loan Portfolio Acquisition and subsequent originations. The average fair value of the portfolio increased 183% year-over-year.
- Revenue Surge: Total investment income more than doubled to $54.3 million, primarily due to the larger asset base. Interest income rose to $49.3 million from $19.9 million.
- Expense Increase: Net operating expenses increased to $21.2 million from $12.2 million. This includes a significant rise in income-based incentive fees ($8.3M vs $2.3M) and management fees ($5.5M vs $1.5M) due to asset growth. However, the Company benefited from an expense limitation agreement waiver of $1.3 million and a voluntary waiver of $0.7 million in G&A expenses.
- Leverage Initiation: In February 2025, the Company entered a $100 million senior secured revolving credit facility. As of year-end, $25 million was drawn, introducing interest expense of $1.25 million for the first time.
- Stock Performance: While NAV increased slightly, the market price declined, widening the discount to NAV from ~7% in 2024 to ~22% in 2025.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Market Environment: Management notes that the cannabis industry is in a nascent growth stage with significant demand for credit-based solutions as equity capital becomes scarce. A December 2025 executive order to expedite the rescheduling of cannabis from Schedule I to Schedule III is viewed as a positive catalyst.
- Investment Pipeline: The Company is currently reviewing approximately $732 million of potential investments.
- Dividend Policy: The Company intends to distribute at least 90% of taxable income to maintain RIC status. The Dividend Reinvestment Plan (DRIP) was terminated effective December 31, 2025; future dividends will be paid in cash.
- Cannabis Regulatory Risk: Cannabis remains illegal under U.S. federal law. Strict enforcement could impair portfolio companies' ability to operate. Rescheduling progress is critical but uncertain.
- Concentration Risk: As of Dec 31, 2025, 74.7% of the portfolio was invested in the cannabis industry. The top three portfolio companies represented 31.8% of total investments.
- Valuation Uncertainty: 100% of the portfolio is categorized as Level 3 assets (unobservable inputs), requiring significant management judgment for fair value determination.
- Liquidity & Leverage: The Company relies on its revolving credit facility for liquidity. A decline in asset values could trigger asset coverage tests, potentially restricting distributions or requiring asset sales.
Investor Verification Checklist
- Verify Portfolio Concentration: Confirm the current percentage of assets allocated to the cannabis sector and the performance of the top three holdings (Verano Holdings, Dreamfields Brands/Jeeter, and others).
- Assess Discount to NAV: Investigate the widening discount (from ~7% to ~22%) and management's strategy to address it, given the inability to issue shares below NAV without stockholder approval.
- Monitor Regulatory Developments: Track the status of the cannabis rescheduling process and any changes in federal enforcement policies that could impact portfolio company viability.
- Review Leverage Utilization: Monitor the drawdown on the $100 million credit facility and the impact of interest rate fluctuations on net investment income.
- Check Dividend Sustainability: Verify that Net Investment Income continues to cover the quarterly dividend rate of $0.34 per share, noting the shift from DRIP to cash-only distributions.